Reuters logo
BRIEF-Zhejiang Hisun Pharmaceutical gets approval for three drugs to enter clinical trials
March 16, 2017 / 10:31 AM / 7 months ago

BRIEF-Zhejiang Hisun Pharmaceutical gets approval for three drugs to enter clinical trials

March 16 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd :

* Says it got approval from China Food and Drug Administration to do clinical trials for three kinds of crud drugs

* The three drugs are used for pulmonary tuberculosis, mammary cancer and hematological malignancies treatment respectively

Source text in Chinese: goo.gl/5bLWcL

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below